Antibiotic resistance is not a single phenomenon but a diverse biological process through which bacteria withstand drugs that would ordinarily inhibit their growth or cause their death. As antibiotic use continues to exert selective pressure on microbial populations, resistant organisms can emerge, persist, and spread across individuals, communities, healthcare environments, animals, and natural ecosystems.
Antibiotic resistance can first be distinguished according to its origin. Intrinsic resistance is an inherent characteristic of a bacterial species. It may arise from natural structural or physiological properties, such as the absence of a drug target, limited membrane permeability, or constitutive expression of protective mechanisms. On the other hand, acquired resistance develops when bacteria gain new genetic information or undergo mutations that alter their susceptibility to an antibiotic. Genetic material responsible for resistance may arise through spontaneous mutation or be transferred between bacteria through mechanisms such as conjugation, transformation, and transduction. This genetic mobility enables resistance traits to move rapidly through microbial populations.
Resistance can also be categorized according to the biological mechanism involved. Enzymatic resistance occurs when bacteria produce enzymes capable of modifying or destroying an antibiotic. β-lactamases, for example, can hydrolyze β-lactam antibiotics and render them ineffective. Target modification occurs when bacterial proteins or cellular structures targeted by antibiotics are altered, preventing the drug from binding effectively. Another mechanism, reduced permeability, limits antibiotic entry into the bacterial cell, while active efflux involves specialized transport proteins that expel antibiotics before they reach inhibitory concentrations.
A further category involves changes in metabolic pathways or cellular processes. Bacteria may develop alternative biochemical routes that bypass the pathway blocked by an antibiotic, or they may protect the drug’s target without directly altering it. Some bacteria can also enter physiological states in which they become temporarily tolerant to antibiotics. These persister cells are not necessarily genetically resistant, but their low metabolic activity can allow them to survive treatment and later repopulate an environment.
Resistance may therefore be viewed as a spectrum of strategies rather than a single bacterial trait. The distinction between intrinsic, acquired, genetic, biochemical, and physiological resistance provides a framework for understanding how antibiotics interact with bacterial evolution. Examining these types collectively reveals why resistance can emerge through multiple pathways and why controlling it requires more than the development of new antimicrobial drugs.
Mechanisms of resistance in pathogenic bacteria
Pathogenic bacteria survive antimicrobial exposure through an array of molecular adaptations that interfere with the activity, access, or cellular consequences of antibiotics (Figure 1). These mechanisms can operate individually or concurrently, allowing bacterial populations to withstand drugs with different chemical structures and cellular targets. Resistance is consequently shaped by the interaction between bacterial genetics, cellular architecture, metabolic state, and antibiotic pressure.
One major mechanism is enzymatic inactivation, in which bacteria synthesize enzymes that chemically modify or destroy antimicrobial compounds. β-lactamases, for instance, cleave the β-lactam ring present in many penicillins and cephalosporins, preventing these drugs from inhibiting cell-wall synthesis. Other enzymes can chemically alter antibiotics through acetylation, phosphorylation, or adenylation, thereby reducing their affinity for bacterial targets.
Modification or protection of antibiotic targets represents another important strategy. Mutations or acquired resistance genes can alter ribosomal components, DNA-processing enzymes, or cell-wall-associated proteins so that antibiotics bind less effectively. In some organisms, resistance proteins physically shield the antimicrobial target without substantially changing its structure. Such alterations can preserve essential cellular functions while diminishing the drug’s pharmacological effect.
Bacteria may also restrict antibiotic accumulation through reduced permeability. Changes in membrane composition or porin proteins can decrease the entry of antimicrobial molecules into the cell. This mechanism is particularly important in Gram-negative pathogens, whose outer membrane already constitutes a formidable permeability barrier. Active efflux removes antibiotics from the bacterial cytoplasm or periplasm through membrane-associated transport systems. Efflux pumps can expel multiple chemically unrelated drugs, contributing to multidrug-resistant phenotypes.
Another mechanism involves metabolic bypass. When an antibiotic blocks an essential biochemical pathway, bacteria may acquire an alternative metabolic route or replace the inhibited cellular function with a resistant variant. This allows physiological processes to continue despite the presence of the antimicrobial agent.
Resistance is also influenced by biofilm-associated adaptation. Within biofilms, bacterial cells become embedded in an extracellular polymeric matrix that can impede antimicrobial penetration and create heterogeneous microenvironments. Nutrient limitation and slow growth within these communities can further reduce susceptibility to antibiotics. Closely related are persister cells, a small subpopulation that enters a transient, low-metabolic state and survives antibiotic exposure without necessarily carrying permanent resistance mutations.
These mechanisms demonstrate that bacterial resistance is multidimensional. Pathogens can neutralize antibiotics, alter their targets, prevent intracellular accumulation, circumvent disrupted pathways, or adopt physiological states that promote survival. Their combined activity enables bacteria to transform antimicrobial exposure from a lethal threat into a selective pressure that favors persistence and subsequent dissemination.
Emergence and persistence of antimicrobial resistance
Antimicrobial resistance (AMR) is the capacity of microorganisms to withstand the inhibitory or lethal effects of antimicrobial agents that would ordinarily suppress their growth or eliminate them. This phenomenon represents a major biological challenge because microorganisms can adapt to antimicrobial pressure through mechanisms that preserve their survival, replication, and transmission. Resistance may be broadly categorized as intrinsic (innate) or acquired, depending on whether the trait is naturally characteristic of the microorganism or develops through the acquisition or modification of genetic determinants.
The clinical significance of AMR extends beyond the survival of individual microorganisms. Resistant pathogens can compromise therapeutic effectiveness, prolong infection, increase the likelihood of treatment failure, and facilitate the persistence and spread of difficult-to-treat infections. Their ability to withstand antimicrobial exposure is often associated with specialized molecular mechanisms, including drug inactivation, modification of antimicrobial targets, alteration of cellular permeability, and active removal of antimicrobial compounds from the cell.
Intrinsic (innate) resistance
Intrinsic (innate) resistance is the naturally occurring ability of a microorganism to withstand the action of an antimicrobial agent without having previously acquired a resistance determinant from another microorganism. It is a constitutive characteristic of the organism and results primarily from its inherent cellular architecture, physiological properties, metabolic pathways, or the natural absence of a susceptible antimicrobial target. In other words, an intrinsically resistant microorganism is not necessarily transformed into a resistant organism by exposure to an antibiotic; rather, its biological characteristics already provide a degree of protection against the antimicrobial compound. This distinction is important because intrinsic resistance forms part of the baseline susceptibility profile of a microbial species and can influence the selection of appropriate antimicrobial therapy.
The structural organization of the bacterial cell envelope is one of the major determinants of intrinsic resistance. Bacteria possess markedly different envelope architectures, and these differences can determine whether an antimicrobial molecule can reach its cellular target at a sufficient concentration. Gram-negative bacteria, for instance, possess an additional outer membrane containing lipopolysaccharide and specialized membrane proteins. This outer membrane functions as a selective permeability barrier and can restrict the entry of numerous antimicrobial compounds. Some drugs that readily penetrate other bacterial cells may have limited access to their targets in Gram-negative organisms. The presence, arrangement, and permeability characteristics of membrane channels can therefore contribute substantially to the natural resistance phenotype.
Intrinsic resistance can also arise when a microorganism lacks the molecular structure targeted by a particular antimicrobial. An antibiotic cannot exert its intended effect if its cellular target is absent or sufficiently different from the form recognized by the drug. Similarly, some organisms naturally possess enzymes, metabolic pathways, or transport systems that reduce the effectiveness of antimicrobial compounds. These characteristics are encoded within the organism’s normal genetic repertoire rather than being newly obtained during antimicrobial exposure.
It is important to distinguish intrinsic resistance from acquired resistance at the genetic and evolutionary levels. Intrinsic resistance generally reflects species- or lineage-associated characteristics that are already present within a microbial population. Acquired resistance, by comparison, results from newly introduced genetic alterations, including mutations or the acquisition of resistance determinants from external sources. Thus, intrinsic resistance should not automatically be attributed to spontaneous mutation. A spontaneous mutation can generate acquired resistance within an initially susceptible population, but the pre-existing structural or physiological features that make an organism naturally resistant constitute intrinsic resistance.
Genetic continuity, mutation, and vertical transmission
Although intrinsic resistance is fundamentally associated with pre-existing biological characteristics, genetic variation can influence the resistance phenotype within a bacterial population. Spontaneous mutations arise naturally during DNA replication as a consequence of occasional errors or other molecular events. Most mutations are neutral or disadvantageous, and only a small proportion may alter a cellular feature in a manner that improves survival during antimicrobial exposure. When such a mutation produces a resistance phenotype, the resulting trait may be inherited by daughter cells through vertical gene transmission during bacterial reproduction.
Vertical transmission refers to the movement of genetic information from a parent cell to its progeny. During bacterial cell division, the chromosome is replicated and distributed between daughter cells, allowing genetic characteristics present in the parental chromosome to persist through subsequent generations. Therefore, when a mutation conferring antimicrobial resistance occurs in a bacterial chromosome, descendants originating from that cell may inherit the altered genetic sequence. Repeated rounds of replication can increase the representation of the resistant lineage within the population, particularly when environmental conditions favor its survival.
The occurrence of a resistance-associated mutation is generally uncommon at the level of an individual replication event. However, bacterial populations can reach very large numbers, creating numerous opportunities for genetic variation to arise. Moreover, antimicrobial exposure can impose selective pressure on a microbial population. Rather than directly causing every bacterium to become resistant, antimicrobial treatment can eliminate susceptible cells while allowing pre-existing resistant variants to survive and reproduce. The resistant organisms consequently become proportionally more abundant. This process illustrates the principle of natural selection: the antimicrobial acts as a selective force, while the underlying genetic variation provides the material upon which selection operates.
AMR selective pressure refers to the environmental filtering effect exerted by antimicrobial drugs, whereby susceptible microorganisms are inhibited or killed, while resistant variants survive. In the presence of an antimicrobial agent, microorganisms carrying resistance mechanisms have a survival advantage and are therefore more likely to reproduce and transmit their resistance traits. Over time, this selective process increases the frequency of resistant microorganisms, allowing them to become predominant within the microbial population.
In some circumstances, resistance may involve the accumulation of multiple mutations rather than a single genetic alteration. Successive changes affecting antimicrobial targets, membrane permeability, regulatory pathways, or cellular transport systems can progressively modify the susceptibility profile of a bacterial strain. The resulting phenotype may therefore reflect the combined contribution of several genetic changes.
Intrinsic resistance and mutation-driven resistance should consequently be viewed as related but distinct concepts. Intrinsic resistance represents a naturally encoded capacity associated with the biology of an organism, whereas mutation-mediated resistance represents a change that emerges within a population and can subsequently be inherited through vertical transmission. Recognizing this distinction provides an essential foundation for understanding the broader development of antimicrobial resistance, including the mechanisms through which bacteria acquire new resistance determinants from other microorganisms and the evolutionary processes that enable resistant populations to persist.
Acquired (phenotypic) resistance
Acquired resistance is the development of a reduced or absent response to an antimicrobial agent by a microorganism that was previously susceptible to that agent. Unlike intrinsic resistance, which is an inherent characteristic of a microbial species, acquired resistance emerges through changes in the organism’s genetic composition or through adaptive responses that enable survival under antimicrobial pressure. In bacteria, this phenomenon is particularly important because resistance determinants can be generated by mutation or obtained from other microorganisms through the exchange of genetic material. Consequently, acquired resistance can transform a susceptible bacterial population into one capable of surviving concentrations of an antimicrobial that would ordinarily inhibit or eliminate it.
The genetic foundation of acquired resistance is closely associated with horizontal gene transfer (HGT) and spontaneous or antimicrobial-selected mutations. HGT permits genetic information to move between bacterial cells independently of ordinary reproduction. Importantly, this exchange is not restricted exclusively to bacteria belonging to the same species. Under appropriate ecological and physiological conditions, resistance-associated genetic material may move between different bacterial species and, in some circumstances, across broader taxonomic boundaries. This capacity for genetic exchange substantially increases the speed at which resistance traits can disseminate within microbial communities.
Three classical mechanisms account for much of the horizontal movement of bacterial DNA in an ecosyste, and they are (1) conjugation, (2) transformation, and (3) transduction. Conjugation involves direct interaction between bacterial cells and commonly facilitates the transfer of plasmids carrying resistance determinants. A plasmid is an extrachromosomal DNA molecule capable of replicating independently of the bacterial chromosome. When a resistance-bearing plasmid is transferred to a susceptible bacterium, the recipient may acquire the capacity to produce enzymes, proteins, or other cellular functions that diminish antimicrobial activity.
Transformation involves the uptake of free DNA fragments from the surrounding environment by a competent bacterial cell. The acquired DNA may subsequently be incorporated into the recipient chromosome through genetic recombination or maintained in another functional form. If the imported genetic material contains a resistance determinant, the recipient cell may consequently express a resistant phenotype.
Transduction, in contrast, is mediated by bacteriophages, viruses that infect bacteria. During the phage replication cycle, bacterial DNA may inadvertently become incorporated into newly formed viral particles. When such a particle infects another bacterium, it can introduce the previously acquired bacterial DNA into the new host. If the transferred material contains an antimicrobial-resistance determinant, transduction can contribute to the dissemination of resistance within a bacterial population.
Acquired resistance should therefore be viewed as a dynamic evolutionary process rather than a single event. Antimicrobial exposure creates a selective environment in which susceptible organisms are disadvantaged while organisms carrying protective genetic characteristics have a greater probability of survival and reproduction. Repeated antimicrobial exposure can consequently enrich resistant subpopulations, particularly when drug concentrations are insufficient to eliminate the entire microbial population or when antimicrobial use creates prolonged selective pressure.
Resistance determinants may be located on the bacterial chromosome or on mobile genetic elements. Chromosomal resistance generally becomes associated with the organism’s stable genetic makeup and may be transmitted to daughter cells during bacterial replication. Extrachromosomal resistance, particularly that associated with plasmids, can be especially significant epidemiologically because mobile DNA can facilitate the movement of resistance determinants between unrelated bacterial cells. The organization of several resistance genes within the same mobile element may also allow a bacterium to acquire resistance to multiple antimicrobial classes simultaneously.
Mechanisms of genetic acquisition and dissemination
The movement of resistance genes is facilitated by several categories of mobile genetic elements (MGEs), including plasmids, transposons, and integrons. Plasmids can function as vehicles for resistance genes and may be transferred between bacterial cells, especially through conjugation. Their independent replication allows acquired genetic information to be retained within the recipient cell and subsequently inherited by its descendants.
Transposons, often referred to as “jumping genes,” are DNA segments capable of moving between different genetic locations. Their mobility enables resistance determinants to relocate within the bacterial chromosome or between chromosomes and plasmids. This mobility can increase the likelihood that a resistance gene becomes associated with a genetic element capable of further dissemination.
Integrons have a different but complementary function. They are genetic systems capable of capturing and expressing gene cassettes, including antimicrobial-resistance genes. Although integrons are not themselves autonomous mobile elements in the same manner as many transposons or plasmids, they can become incorporated into mobile DNA structures and thereby contribute indirectly to the spread of resistance. The combined activity of integrons, transposons, and plasmids creates a highly effective genetic network through which multiple resistance determinants can accumulate and circulate among bacterial populations.
Acquired resistance can therefore arise through several interconnected routes: mutation, transformation, transduction, conjugation, and movement of resistance determinants through mobile genetic elements. Once established, a resistance determinant may be maintained within the chromosome or persist on extrachromosomal DNA such as plasmids. Its continued presence depends on factors including the biological fitness of the host, the stability of the genetic element, environmental conditions, and the degree of antimicrobial selection.
From a microbiological perspective, the significance of acquired resistance lies in its ability to accelerate bacterial adaptation. A resistance trait does not necessarily need to originate independently in every bacterial cell; genetic information generated or maintained in one population can become available to other populations through genetic exchange. This interconnectedness enables resistance to spread through microbial communities and creates opportunities for the accumulation of multiple resistance mechanisms within individual pathogens.
References
Ashutosh Kar (2008). Pharmaceutical Microbiology, 1st edition. New Age International Publishers: New Delhi, India.
Axelsen P.H (2002). Essentials of antimicrobial pharmacology. Humana Press, Totowa, New Jersey, USA. Al-Jasser A.M (2006). Extended – Spectrum Beta – Lactamases (ESBLs): A Global Problem. Kuwait Medical Journal, 38(3):171-185.
Ejikeugwu P.C., Ugwu C.M., Araka C.O., Gugu T.H., Iroha I.R., Adikwu M.U and Esimone C.O (2012). Imipenem and Meropenem resistance amongst ESBL producing Escherichia coli and Klebsiella pneumoniae clinical isolates. International Research Journal of Microbiology. 3(10):339-344.
Finch R.G, Greenwood D, Norrby R and Whitley R (2002). Antibiotic and chemotherapy, 8th edition. Churchill Livingstone, London and Edinburg.
Galgano, M., Pellegrini, F., Catalano, E., Capozzi, L., Del Sambro, L., Sposato, A., Lucente, M. S., Vasinioti, V. I., Catella, C., Odigie, A. E., Tempesta, M., Pratelli, A., & Capozza, P. (2025). Acquired bacterial resistance to antibiotics and resistance genes: From past to future. Antibiotics, 14(3), 222.
Kapoor, G., Saigal, S., & Elongavan, A. (2017). Action and resistance mechanisms of antibiotics: A guide for clinicians. Journal of Anaesthesiology Clinical Pharmacology, 33(3), 300–305.
Larsson, D. G. J., & Flach, C. F. (2022). Antibiotic resistance in the environment. Nature Reviews Microbiology, 20, 257–269.
Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Microbiology Spectrum, 4(2).
Nimmana, B. K., & Nguyen, A. D. (2026). Antibiotic resistance. In StatPearls. StatPearls Publishing. www.ncbi.nlm.nih.gov/books/NBK513277/
Petchiappan, A., & Chatterji, D. (2017). Antibiotic resistance: Current perspectives. ACS Omega, 2(10), 7400–7409.
Livermore D.M (2004). The need for new antibiotics. Clinical Microbiology & Infection, 4(10): 1-9.
Mascaretti O.A (2003). Bacteria versus antibacterial agents: An integrated approach. Washington: ASM Press.
Discover more from Microbiology Class
Subscribe to get the latest posts sent to your email.
